Nebenwirkungen · Elrexfio
ELREXFIO 40 mg/mL solution for injection · Abschnitt 4.8 · PDF-Seite 12
HOS-150163 · Präparat HOS-100256
Adverse reactions are listed according to the MedDRA system organ classification and by frequency. Frequency categories are defined as very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1 000 to < 1/100), rare (≥ 1/10 000 to < 1/1 000), very rare (< 1/10 000) and not known (frequency cannot be estimated from the available data). Within each frequency grouping, where relevant, adverse reactions are presented in order of decreasing seriousness.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-01-16T10:56:00Z · SHA-256 ec0f4a679d2a7d6174fef968d6a1f360599c3f73a460f0ffb9ca69435091340a · Passage cbe6ab02f29333e2c612c6bffccc89000f77c2d4a628a4cbb1766442c6d42ea2 · Zeichen 1278–1737 im Abschnitt